Value through Innovation27 July 2016

Clinical Study Results

  • Telmisartan + Simvastatin - Hypertension
    Clinical Study Number 1228.1
    Study Indication Hypertension
    Product Telmisartan + Simvastatin
    Generic Name Telmisartan + Simvastatin
    Lab Code
    Clinical Phase II
    Study Title

    Reduced factorial design, randomized, double-blind trial comparing combinations of telmisartan 20 or 80 mg and simvastatin 20 or 40 mg with single component therapies in the treatment of hypertension and dyslipidemia

    Study Document Trial synopsis 1228.1_DR english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.